Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Risitano · SciRah

Researcher profile · Semantic Scholar

A. Risitano

Share profile

A. Risitano — researcher profile on SciRah

h-index: 61
Works: 347
Citations: 15K

Most-cited papers

Complement as a target in COVID-19?
A. Risitano, D. Mastellos, M. Huber-Lang, Despina Yancopoulou +3 more
2020Nature reviews. Immunology461 citations Open access
Semantic Scholar
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.
P. Hillmen, J. Szer, I. Weitz, A. Röth +15 more
2021New England Journal of Medicine306 citations Open access
Semantic Scholar
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
R. Peffault de Latour, A. Kulasekararaj, S. Iacobelli, Sofie R. Terwel +46 more
2022New England Journal of Medicine194 citations Open access
Semantic Scholar
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria.
R. Peffault de Latour, A. Röth, A. Kulasekararaj, Bing Han +49 more
2024New England Journal of Medicine97 citations Open access
Semantic Scholar
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial.
A. Risitano, A. Röth, J. Soret, C. Frieri +11 more
2021The Lancet Haematology82 citations
Semantic Scholar
Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond.
E. Gavriilaki, R. Peffault de Latour, A. Risitano
2021Blood73 citations Open access
Semantic Scholar
Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab
A. Kulasekararaj, A. Risitano, J. Maciejewski, R. Notaro +5 more
2021Blood69 citations Open access
Semantic Scholar
How we(’ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future
A. Risitano, R. Peffault de Latour
2021British Journal of Haematology62 citations Open access
Semantic Scholar
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial.
R. de Latour, J. Szer, I. Weitz, A. Röth +14 more
2022The Lancet Haematology59 citations Open access
Semantic Scholar
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy.
J. Mariotti, A. Raiola, A. Evangelista, A. Carella +27 more
2020Blood Advances58 citations Open access
Semantic Scholar
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial.
Jong Wook Lee, Morag Griffin, Jin Seok Kim, Lily Wong Lee Lee +9 more
2023The Lancet Haematology57 citations
Semantic Scholar
Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life study
P. Debureaux, A. Kulasekararaj, F. Cacace, B. Silva +14 more
2021Bone Marrow Transplantation55 citations
Semantic Scholar
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101
P. Skendros, Georgios S. Germanidis, D. Mastellos, C. Antoniadou +31 more
2022Science Advances51 citations Open access
Semantic Scholar
The complement alternative pathway in paroxysmal nocturnal hemoglobinuria: From a pathogenic mechanism to a therapeutic target
A. Risitano, C. Frieri, E. Urciuoli, L. Marano
2022Immunological Reviews49 citations Open access
Semantic Scholar
C3-targeted therapy in periodontal disease: moving closer to the clinic
G. Hajishengallis, H. Hasturk, John D Lambris, D. Apatzidou +29 more
2021Trends in immunology47 citations Open access
Semantic Scholar
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study
S. Giammarco, S. Sica, P. Chiusolo, L. Laurenti +7 more
2021International journal of hematology32 citations
Semantic Scholar
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab
A. Bacigalupo, E. Angelucci, A. Raiola, R. Varaldo +21 more
2020Bone Marrow Transplantation29 citations
Semantic Scholar
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs.
C. Girmenia, W. Barcellini, P. Bianchi, E. di Bona +7 more
2022Blood reviews25 citations
Semantic Scholar
Author Correction: Complement as a target in COVID-19?
A. Risitano, D. Mastellos, M. Huber-Lang, Despina Yancopoulou +3 more
2020Nature reviews. Immunology24 citations Open access
Semantic Scholar
Hepatitis-associated aplastic anemia.
Alfadel Alshaibani, C. Dufour, A. Risitano, R. de Latour +1 more
2020Hematology/Oncology and Stem Cell Therapy22 citations Open access
Semantic Scholar
Stem Cell Transplantation for Diamond-Blackfan Anemia. A Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT).
M. Miano, D. Eikema, J. de la Fuente, P. Bosman +35 more
2021Transplantation and Cellular Therapy21 citations Open access
Semantic Scholar
Pegcetacoplan versus Eculizumab in PNH. Reply.
P. Hillmen, A. Risitano, R. Peffault de Latour
2021New England Journal of Medicine20 citations
Semantic Scholar
Discovering C3 targeting therapies for paroxysmal nocturnal hemoglobinuria: Achievements and pitfalls.
A. Risitano, R. Peffault de Latour, L. Marano, C. Frieri
2022Seminars in Immunology19 citations
Semantic Scholar
Hemolytic paroxysmal nocturnal hemoglobinuria: 20 years of medical progress.
R. Peffault de Latour, K. Hosokawa, A. Risitano
2022Seminars in hematology (Print)18 citations Open access
Semantic Scholar
Haplo‐identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: Results from the Severe Aplastic Anemia Working Party of the EBMT
J. Zubicaray, D. Pagliara, J. Sevilla, D. Eikema +21 more
2021American journal of hematology/oncology18 citations Open access
Semantic Scholar
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT
R. Swoboda, M. Labopin, S. Giebel, E. Angelucci +19 more
2022Bone Marrow Transplantation17 citations
Semantic Scholar
Vemircopan (ALXN2050) Monotherapy in Paroxysmal Nocturnal Hemoglobinuria: Interim Data from a Phase 2 Open-Label Proof-of-Concept Study
P. Browett, A. Kulasekararaj, R. Notaro, M. Ogawa +3 more
2022Blood16 citations Open access
Semantic Scholar
Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH)
Kimmo Weisshaar, H. Ewald, J. Halter, S. Gerull +11 more
2020Orphanet Journal of Rare Diseases16 citations Open access
Semantic Scholar
Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial
A. Risitano, A. Kulasekararaj, A. Roeth, P. Scheinberg +33 more
2023Blood15 citations Open access
Semantic Scholar
The long‐acting anti‐C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab
M. Sica, F. Barone, Caterina Nannelli, Patrizia Ricci +5 more
2023British Journal of Haematology15 citations Open access
Semantic Scholar
Upfront unrelated donor hematopoietic stem cell transplantation in patients with idiopathic aplastic anemia: A retrospective study of the Severe Aplastic Anemia Working Party of European Bone Marrow Transplantation
A. Petit, A. Kulasekararaj, D. Eikema, A. Maschan +12 more
2021American journal of hematology/oncology15 citations Open access
Semantic Scholar
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry
G. Limongelli, Stefano Iucolano, E. Monda, Pasquale Elefante +118 more
2021Journal of public health15 citations Open access
Semantic Scholar
Ruxolitinib for steroid-resistant acute GVHD.
A. Risitano, R. Peffault de Latour
2020Blood15 citations
Semantic Scholar
Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT
R. Devillier, D. Eikema, C. Dufour, M. Aljurf +20 more
2023Haematologica14 citations Open access
Semantic Scholar
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study
S. Leotta, U. Markovic, Maria Cristina Pirosa, Stefania Stella +20 more
2021Annals of Hematology13 citations
Semantic Scholar
Infectious Agents and Bone Marrow Failure: A Causal or a Casual Connection?
Valentina Giudice, A. Risitano, C. Selleri
2021Frontiers in Medicine11 citations Open access
Semantic Scholar
Clinical Breakthrough Hemolysis (BTH) during Monotherapy with the Oral Factor B Inhibitor Iptacopan Is Generally Not Severe and Managed without Treatment Discontinuation: 48-Week Data from the Phase III Apply-PNH and Appoint-PNH Trials in Paroxysmal Nocturnal Hemoglobinuria (PNH)
R. Peffault de Latour, A. Kulasekararaj, P. Scheinberg, Philippe Ferber +4 more
2023Blood10 citations Open access
Semantic Scholar
Oral Dysplastic Complications after HSCT: Single Case Series of Multidisciplinary Evaluation of 80 Patients
S. Leuci, Noemi Coppola, A. Blasi, E. Ruoppo +5 more
2020Life10 citations Open access
Semantic Scholar
Danicopan As Add-on Therapy to Ravulizumab or Eculizumab Versus Placebo in Patients with Paroxysmal Nocturnal Hemoglobinuria and Clinically Significant Extravascular Hemolysis: Phase 3 Long-Term Data
A. Kulasekararaj, M. Griffin, C. Piatek, J. Shammo +10 more
2023Blood9 citations Open access
Semantic Scholar
Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation
S. Pagliuca, A. Kulasekararaj, D. Eikema, Brian Piepenbroek +22 more
2023Haematologica9 citations Open access
Semantic Scholar
Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group.
F. Bonifazi, S. Sica, A. Angeletti, S. Marktel +20 more
2020Transplantation9 citations Open access
Semantic Scholar
P826: FACTOR D INHIBITION WITH ORAL BCX9930 LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS
A. Kulasekararaj, W. Füreder, A. McDonald, J. Malherbe +9 more
2022HemaSphere7 citations Open access
Semantic Scholar
Dyskeratosis congenita and squamous cell carcinoma of the mandibular alveolar ridge
A. Manfuso, A. Risitano, C. Copelli
2021BMJ Case Reports7 citations Open access
Semantic Scholar
Results of the Pegasus Phase 3 Randomized Trial Demonstrating Superiority of the C3 Inhibitor, Pegcetacoplan, Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria
P. Hillmen, Jeffrey Szer, I. Weitz, A. Röth +14 more
20207 citations
Semantic Scholar
Alternative Donor Transplantation for Severe Aplastic Anemia: A Comparative Study of the Saawp EBMT
J. Montoro, D. Eikema, Joe Tuffnell, Victoria T. Potter +22 more
2023Blood6 citations Open access
Semantic Scholar
S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS
A. Röth, G. He, A. Brodsky, C. Chai-Adisaksopha +15 more
2023HemaSphere6 citations Open access
Semantic Scholar
Efficacy matters: broadening complement inhibition in COVID-19
D. Mastellos, P. Skendros, R. Calado, A. Risitano +1 more
2020The Lancet Rheumatology6 citations Open access
Semantic Scholar
Categorization of Hematological Responses to Oral Iptacopan Monotherapy in Anti-C5-Treated Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia in the Phase III APPLY-PNH Trial and Complement Inhibitor-Naïve Patients in the Phase III APPOINT-PNH Trial
A. Risitano, Bing Han, A. Kulasekararaj, Y. Ueda +7 more
2023Blood5 citations Open access
Semantic Scholar
3113 – FORTY-EIGHT WEEK EFFICACY AND SAFETY OF PEGCETACOPLAN IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND SUBOPTIMAL RESPONSE TO PRIOR ECULIZUMAB TREATMENT
R. de Latour, J. Szer, Ilene Weitz, A. Röth +14 more
2021Experimental Hematology5 citations Open access
Semantic Scholar
BCX9930, a Potent, Selective, Oral Factor D Inhibitor, Demonstrates Proof-of-Concept As Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
A. Kulasekararaj, Jacques Le Roux Malherbe, A. Mcdonald, M. Cornpropst +7 more
20205 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Peffault de Latour×18
Invite
R. Peffault de Latour — researcher profile on SciRah
A. Kulasekararaj×11
Invite
A. Kulasekararaj — researcher profile on SciRah
M. Griffin×9
Invite
M. Griffin — researcher profile on SciRah
A. Röth×7
Invite
A. Röth — researcher profile on SciRah

×7

Invite

R. de Latour — researcher profile on SciRah

Invite

L. Marano — researcher profile on SciRah

Invite

C. Frieri — researcher profile on SciRah

Invite

J. Panse — researcher profile on SciRah

C. de Castro×6

Invite

C. de Castro — researcher profile on SciRah

F. Sicre de Fontbrune×6

Invite

F. Sicre de Fontbrune — researcher profile on SciRah

Invite

S. Sica — researcher profile on SciRah

Invite

D. Eikema — researcher profile on SciRah